Cargando…
A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis
Thrombocytopenia is a serious issue connected with the pathogenesis of several human diseases including chronic inflammation, arthritis, Alzheimer's disease, cardiovascular diseases (CVDs) and other oxidative stress-associated pathologies. The indiscriminate use of antibiotics and other biologi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169656/ https://www.ncbi.nlm.nih.gov/pubmed/25238069 http://dx.doi.org/10.1371/journal.pone.0107182 |
_version_ | 1782335749830475776 |
---|---|
author | Rakesh, Kodagahalli S. Jagadish, Swamy Vinayaka, Ajjampura C. Hemshekhar, Mahadevappa Paul, Manoj Thushara, Ram M. Sundaram, Mahalingam S. Swaroop, Toreshettahally R. Mohan, Chakrabhavi D. Basappa, Sadashiva, Marilinganadoddi P. Kemparaju, Kempaiah Girish, Kesturu S. Rangappa, Kanchugarakoppal S. |
author_facet | Rakesh, Kodagahalli S. Jagadish, Swamy Vinayaka, Ajjampura C. Hemshekhar, Mahadevappa Paul, Manoj Thushara, Ram M. Sundaram, Mahalingam S. Swaroop, Toreshettahally R. Mohan, Chakrabhavi D. Basappa, Sadashiva, Marilinganadoddi P. Kemparaju, Kempaiah Girish, Kesturu S. Rangappa, Kanchugarakoppal S. |
author_sort | Rakesh, Kodagahalli S. |
collection | PubMed |
description | Thrombocytopenia is a serious issue connected with the pathogenesis of several human diseases including chronic inflammation, arthritis, Alzheimer's disease, cardiovascular diseases (CVDs) and other oxidative stress-associated pathologies. The indiscriminate use of antibiotics and other biological drugs are reported to result in thrombocytopenia, which is often neglected during the treatment regime. In addition, augmented oxidative stress induced by drugs and pathological conditions has also been shown to induce thrombocytopenia, which seems to be the most obvious consequence of elevated rate of platelet apoptosis. Thus, blocking oxidative stress-induced platelet apoptosis would be of prime importance in order to negotiate thrombocytopenia and associated human pathologies. The current study presents the synthesis and platelet protective nature of novel ibuprofen derivatives. The potent anti-oxidant ibuprofen derivative 4f was selected for the study and the platelet protective efficacy and platelet aggregation inhibitory property has been demonstrated. The compound 4f dose dependently mitigates the oxidative stress-induced platelet apoptosis in both platelet rich plasma and washed platelets. The platelet protective nature of compound 4f was determined by assessing various apoptotic markers such as ROS generation, cytosolic Ca(2+) levels, PS externalization, cytochrome C translocation, Caspase activation, mitochondrial membrane depolarization, cytotoxicity, LDH leakage and tyrosine phosphorylation of cytosolic proteins. Furthermore, compound 4f dose dependently ameliorated agonist induced platelet aggregation. Therefore, compound 4f can be estimated as a potential candidate in the treatment regime of pathological disorders associated with platelet activation and apoptosis. In addition, compound 4f can be used as an auxiliary therapeutic agent in pathologies associated with thrombocytopenia. |
format | Online Article Text |
id | pubmed-4169656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41696562014-09-22 A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis Rakesh, Kodagahalli S. Jagadish, Swamy Vinayaka, Ajjampura C. Hemshekhar, Mahadevappa Paul, Manoj Thushara, Ram M. Sundaram, Mahalingam S. Swaroop, Toreshettahally R. Mohan, Chakrabhavi D. Basappa, Sadashiva, Marilinganadoddi P. Kemparaju, Kempaiah Girish, Kesturu S. Rangappa, Kanchugarakoppal S. PLoS One Research Article Thrombocytopenia is a serious issue connected with the pathogenesis of several human diseases including chronic inflammation, arthritis, Alzheimer's disease, cardiovascular diseases (CVDs) and other oxidative stress-associated pathologies. The indiscriminate use of antibiotics and other biological drugs are reported to result in thrombocytopenia, which is often neglected during the treatment regime. In addition, augmented oxidative stress induced by drugs and pathological conditions has also been shown to induce thrombocytopenia, which seems to be the most obvious consequence of elevated rate of platelet apoptosis. Thus, blocking oxidative stress-induced platelet apoptosis would be of prime importance in order to negotiate thrombocytopenia and associated human pathologies. The current study presents the synthesis and platelet protective nature of novel ibuprofen derivatives. The potent anti-oxidant ibuprofen derivative 4f was selected for the study and the platelet protective efficacy and platelet aggregation inhibitory property has been demonstrated. The compound 4f dose dependently mitigates the oxidative stress-induced platelet apoptosis in both platelet rich plasma and washed platelets. The platelet protective nature of compound 4f was determined by assessing various apoptotic markers such as ROS generation, cytosolic Ca(2+) levels, PS externalization, cytochrome C translocation, Caspase activation, mitochondrial membrane depolarization, cytotoxicity, LDH leakage and tyrosine phosphorylation of cytosolic proteins. Furthermore, compound 4f dose dependently ameliorated agonist induced platelet aggregation. Therefore, compound 4f can be estimated as a potential candidate in the treatment regime of pathological disorders associated with platelet activation and apoptosis. In addition, compound 4f can be used as an auxiliary therapeutic agent in pathologies associated with thrombocytopenia. Public Library of Science 2014-09-19 /pmc/articles/PMC4169656/ /pubmed/25238069 http://dx.doi.org/10.1371/journal.pone.0107182 Text en © 2014 Rakesh et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Rakesh, Kodagahalli S. Jagadish, Swamy Vinayaka, Ajjampura C. Hemshekhar, Mahadevappa Paul, Manoj Thushara, Ram M. Sundaram, Mahalingam S. Swaroop, Toreshettahally R. Mohan, Chakrabhavi D. Basappa, Sadashiva, Marilinganadoddi P. Kemparaju, Kempaiah Girish, Kesturu S. Rangappa, Kanchugarakoppal S. A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis |
title | A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis |
title_full | A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis |
title_fullStr | A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis |
title_full_unstemmed | A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis |
title_short | A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis |
title_sort | new ibuprofen derivative inhibits platelet aggregation and ros mediated platelet apoptosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169656/ https://www.ncbi.nlm.nih.gov/pubmed/25238069 http://dx.doi.org/10.1371/journal.pone.0107182 |
work_keys_str_mv | AT rakeshkodagahallis anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT jagadishswamy anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT vinayakaajjampurac anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT hemshekharmahadevappa anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT paulmanoj anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT thushararamm anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT sundarammahalingams anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT swarooptoreshettahallyr anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT mohanchakrabhavid anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT basappa anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT sadashivamarilinganadoddip anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT kemparajukempaiah anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT girishkesturus anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT rangappakanchugarakoppals anewibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT rakeshkodagahallis newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT jagadishswamy newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT vinayakaajjampurac newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT hemshekharmahadevappa newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT paulmanoj newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT thushararamm newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT sundarammahalingams newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT swarooptoreshettahallyr newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT mohanchakrabhavid newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT basappa newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT sadashivamarilinganadoddip newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT kemparajukempaiah newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT girishkesturus newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis AT rangappakanchugarakoppals newibuprofenderivativeinhibitsplateletaggregationandrosmediatedplateletapoptosis |